Introduction
Evidence has been accumulating for the involvement of pro¬ gesterone in the regulation of endometrial oxytocin receptors in ewes. The increase in the concentration of oxytocin receptors around luteolysis in ewes has been shown to coincide with a fall in the concentrations of progesterone in plasma (Roberts et al, 1976; Sheldrick and Flint, 1985) . In parturient rats, treatment with a PG synthetase inhibitor, Naproxen, reduced the concen¬ trations of oxytocin receptors, whereas co-administration of PG increased the receptor concentrations (Chan, 1987; Chan et al, 1988) . However, the maintenance of the corpus luteum is associated with the maintenance of high concentrations of pro¬ gesterone in plasma and exogenous progesterone given to ovariectomized ewes for [10] [11] [12] days can reduce the concen¬ trations of oxytocin receptors in the endometrium (Vallet et al, 1990; Lau et al, 1992a) . Withdrawal of progesterone treatment was followed by a rapid rebound in the concentrations of endometrial oestrogen receptors in the nucleus (Leavitt et al, 1985) and endometrial oxytocin receptors (Leavitt et al, 1985;  'Present address: Department of Obstetrics (Fairclough et al, 1975) used in our laboratory. The corre¬ lation coefficient between the two assays was 0.996 (n = 10) (Parr, 1991) . The intra-and interassay coefficients of variation, for a plasma pool collected from pregnant ewes on day 10 of pregnancy, were 6.5% (n = 10) and 12.6% (n = 10), respectively.
Assay of endometrial oxytocin receptors
The endometrial microsomal fractions containing oxytocin receptors were prepared and the oxytocin receptors were measured by a receptor-binding assay described by Lau et al (1992a) . All samples were measured in one assay and the intraassay coefficient of variation for the receptor binding radio¬ immunoassay was 3% (n = 4). The receptor-binding data were subjected to Scatchard (1949) (Fig. 3) (Vallet et al, 1990; Lau et al, 1992a, b) .
In the progesterone-treated and Finadyne-treated ewes that had plasma progesterone concentrations maintained over the time of luteolysis, the concentrations of oxytocin receptors were intermediate compared with the values observed at luteo¬ lysis (this study; Sheldrick and Flint, 1985) and during the late luteal phase (Sheldrick and Flint, 1985 Chan (1987) and Chan et al, (1988) in parturient rats. Chan (1987) and Chan et al (1988) showed that treatment with Naproxen (a PG synthetase inhibitor) reduced the concentrations of oxytocin receptors, whereas coadministration of PG increased the concentrations of oxytocin receptors. As administration of a PG synthetase inhibitor would block the release of PGF2ct (Barcikoski et al, 1974) leading to the maintenance of luteal function and high plasma progesterone concentrations, the reduction in the concentrations of oxytocin receptors following the administration of a PG synthetase inhibitor (this study; Chan, 1987; Chan et al, 1988) (Leavitt et al, 1985) and uterine oxytocin receptors (Leavitt et al, 1985; Vallet et al, 1990; Lau et al, 1992b) in ovariectomized ewes regardless of whether a constant infusion of oestradiol was given. Withdrawal of pro¬ gesterone treatment was followed by an increase in the concen¬ trations of oestrogen receptors in the nucleus (Leavitt et al, 1985) and uterine oxytocin receptors (Leavitt et al, 1985; Lau et al, 1992b 
